The Chromatin Accessibility Landscape of Nonalcoholic Fatty Liver Disease Progression |
Kang, Byeonggeun
(Department of Biological Sciences, Institute of Molecular Biology & Genetics, Seoul National University)
Kang, Byunghee (Department of Life Sciences, Pohang University of Science and Technology (POSTECH)) Roh, Tae-Young (Department of Life Sciences, Pohang University of Science and Technology (POSTECH)) Seong, Rho Hyun (Department of Biological Sciences, Institute of Molecular Biology & Genetics, Seoul National University) Kim, Won (Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine) |
1 | Kleiner, D.E., Brunt, E.M., Van Natta, M., Behling, C., Contos, M.J., Cummings, O.W., Ferrell, L.D., Liu, Y.C., Torbenson, M.S., Unalp-Arida, A., et al. (2005). Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313-1321. DOI |
2 | Langmead, B. and Salzberg, S.L. (2012). Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357-359. DOI |
3 | Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., and 1000 Genome Project Data Processing Subgroup (2009). The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079. DOI |
4 | Lyu, Z., Ma, M., Xu, Y., Wang, X., Zhu, Y., Ren, W., and Li, T. (2020). Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma. Int. J. Clin. Oncol. 25, 1334-1345. DOI |
5 | Oh, S., Jo, Y., Jung, S., Yoon, S., and Yoo, K.H. (2020). From genome sequencing to the discovery of potential biomarkers in liver disease. BMB Rep. 53, 299-310. DOI |
6 | Riggi, N., Knoechel, B., Gillespie, S.M., Rheinbay, E., Boulay, G., Suva, M.L., Rossetti, N.E., Boonseng, W.E., Oksuz, O., Cook, E.B., et al. (2014). EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma. Cancer Cell 26, 668-681. DOI |
7 | Sanyal, A.J., Van Natta, M.L., Clark, J., Neuschwander-Tetri, B.A., Diehl, A., Dasarathy, S., Loomba, R., Chalasani, N., Kowdley, K., Hameed, B., et al. (2021). Prospective study of outcomes in adults with nonalcoholic fatty liver disease. N. Engl. J. Med. 385, 1559-1569. DOI |
8 | Shia, W.J., Pattenden, S.G., and Workman, J.L. (2006). Histone H4 lysine 16 acetylation breaks the genome's silence. Genome Biol. 7, 217. DOI |
9 | Sliz, E., Sebert, S., Wurtz, P., Kangas, A.J., Soininen, P., Lehtimaki, T., Kahonen, M., Viikari, J., Mannikko, M., Ala-Korpela, M., et al. (2018). NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects. Hum. Mol. Genet. 27, 2214-2223. DOI |
10 | Yoo, T., Joo, S.K., Kim, H.J., Kim, H.Y., Sim, H., Lee, J., Kim, H.H., Jung, S., Lee, Y., Jamialahmadi, O., et al. (2021). Disease-specific eQTL screening reveals an anti-fibrotic effect of AGXT2 in non-alcoholic fatty liver disease. J. Hepatol. 75, 514-523. DOI |
11 | Loomba, R., Gindin, Y., Jiang, Z., Lawitz, E., Caldwell, S., Djedjos, C.S., Xu, R., Chung, C., Myers, R.P., Subramanian, G.M., et al. (2018). DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis. JCI Insight 3, e96685. DOI |
12 | Zhang, Y., Liu, T., Meyer, C.A., Eeckhoute, J., Johnson, D.S., Bernstein, B.E., Nusbaum, C., Myers, R.M., Brown, M., Li, W., et al. (2008). Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137. DOI |
13 | Amemiya, H.M., Kundaje, A., and Boyle, A.P. (2019). The ENCODE blacklist: identification of problematic regions of the genome. Sci. Rep. 9, 9354. DOI |
14 | Brunt, E.M., Kleiner, D.E., Wilson, L.A., Belt, P., Neuschwander-Tetri, B.A., and NASH Clinical Research Network (CRN) (2011). Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 53, 810-820. DOI |
15 | Cholankeril, G., Patel, R., Khurana, S., and Satapathy, S.K. (2017). Hepatocellular carcinoma in non-alcoholic steatohepatitis: current knowledge and implications for management. World J. Hepatol. 9, 533-543. DOI |
16 | Gelbart, M.E., Larschan, E., Peng, S., Park, P.J., and Kuroda, M.I. (2009). Drosophila MSL complex globally acetylates H4K16 on the male X chromosome for dosage compensation. Nat. Struct. Mol. Biol. 16, 825-832. DOI |
17 | Kim, E., Kim, D., Lee, J.S., Yoe, J., Park, J., Kim, C.J., Jeong, D., Kim, S., and Lee, Y. (2018). Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4-MMP1 axis. Hepatology 67, 2287-2301. DOI |
18 | Lake, A.D., Chaput, A.L., Novak, P., Cherrington, N.J., and Smith, C.L. (2016). Transcription factor binding site enrichment analysis predicts drivers of altered gene expression in nonalcoholic steatohepatitis. Biochem. Pharmacol. 122, 62-71. DOI |
19 | McLean, C.Y., Bristor, D., Hiller, M., Clarke, S.L., Schaar, B.T., Lowe, C.B., Wenger, A.M., and Bejerano, G. (2010). GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28, 495-501. DOI |
20 | Ross-Innes, C.S., Stark, R., Teschendorff, A.E., Holmes, K.A., Ali, H.R., Dunning, M.J., Brown, G.D., Gojis, O., Ellis, I.O., Green, A.R., et al. (2012). Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 481, 389-393. DOI |
21 | Schuster, S., Cabrera, D., Arrese, M., and Feldstein, A.E. (2018). Triggering and resolution of inflammation in NASH. Nat. Rev. Gastroenterol. Hepatol. 15, 349-364. DOI |
22 | Seki, E., De Minicis, S., Osterreicher, C.H., Kluwe, J., Osawa, Y., Brenner, D.A., and Schwabe, R.F. (2007). TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 13, 1324-1332. DOI |
23 | Bailey, T.L., Johnson, J., Grant, C.E., and Noble, W.S. (2015). The MEME Suite. Nucleic Acids Res. 43(W1), W39-W49. DOI |
24 | Brunt, E.M., Janney, C.G., Di Bisceglie, A.M., Neuschwander-Tetri, B.A., and Bacon, B.R. (1999). Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 94, 2467-2474. DOI |
25 | Buenrostro, J.D., Giresi, P.G., Zaba, L.C., Chang, H.Y., and Greenleaf, W.J. (2013). Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213-1218. DOI |
26 | Elbadawy, M., Yamanaka, M., Goto, Y., Hayashi, K., Tsunedomi, R., Hazama, S., Nagano, H., Yoshida, T., Shibutani, M., Ichikawa, R., et al. (2020). Efficacy of primary liver organoid culture from different stages of non-alcoholic steatohepatitis (NASH) mouse model. Biomaterials 237, 119823. DOI |
27 | Govaere, O., Cockell, S., Tiniakos, D., Queen, R., Younes, R., Vacca, M., Alexander, L., Ravaioli, F., Palmer, J., Petta, S., et al. (2020). Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. Sci. Transl. Med. 12, eaba4448. DOI |
28 | Khan, A., Fornes, O., Stigliani, A., Gheorghe, M., Castro-Mondragon, J.A., van der Lee, R., Bessy, A., Cheneby, J., Kulkarni, S.R., Tan, G., et al. (2018). JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework. Nucleic Acids Res. 46(D1), D260-D266. DOI |
29 | Corces, M.R., Trevino, A.E., Hamilton, E.G., Greenside, P.G., Sinnott-Armstrong, N.A., Vesuna, S., Satpathy, A.T., Rubin, A.J., Montine, K.S., Wu, B., et al. (2017). An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat. Methods 14, 959-962. DOI |
30 | Marcher, A.B., Bendixen, S.M., Terkelsen, M.K., Hohmann, S.S., Hansen, M.H., Larsen, B.D., Mandrup, S., Dimke, H., Detlefsen, S., and Ravnskjaer, K. (2019). Transcriptional regulation of Hepatic Stellate Cell activation in NASH. Sci. Rep. 9, 2324. DOI |
31 | Choi, W.Y., Hwang, J.H., Cho, A.N., Lee, A.J., Jung, I., Cho, S.W., Kim, L.K., and Kim, Y.J. (2020). NEUROD1 intrinsically initiates differentiation of induced pluripotent stem cells into neural progenitor cells. Mol. Cells 43, 1011-1022. DOI |
32 | Kim, J.Y., Park, K.J., Hwang, J.Y., Kim, G.H., Lee, D., Lee, Y.J., Song, E.H., Yoo, M.G., Kim, B.J., Suh, Y.H., et al. (2017). Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis. J. Hepatol. 67, 349-359. DOI |